Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Frederic Ira Preffer, Ph.D.

Co-Author

This page shows the publications co-authored by Frederic Preffer and A. Cosimi.
Connection Strength

0.682
  1. Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. Am J Transplant. 2014 Jul; 14(7):1599-611.
    View in: PubMed
    Score: 0.145
  2. Association of natural killer cell depletion with induction of mixed chimerism and allograft tolerance in non-human primates. Transplantation. 2000 Jul 27; 70(2):368-74.
    View in: PubMed
    Score: 0.055
  3. CDR-grafted OKT4A monoclonal antibody in cynomolgus renal allograft recipients. Transplantation. 1994 Mar 27; 57(6):788-93.
    View in: PubMed
    Score: 0.036
  4. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation. 1993 Apr; 55(4):766-72; discussion 772-3.
    View in: PubMed
    Score: 0.033
  5. Immunosuppression of cynomolgus renal allograft recipients with humanized OKT4A monoclonal antibodies. Transplant Proc. 1993 Feb; 25(1 Pt 1):784-5.
    View in: PubMed
    Score: 0.033
  6. The effects of OKT4A monoclonal antibody on cellular immunity of nonhuman primate renal allograft recipients. Transplantation. 1992 Mar; 53(3):501-7.
    View in: PubMed
    Score: 0.031
  7. Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am J Transplant. 2011 Jul; 11(7):1464-77.
    View in: PubMed
    Score: 0.029
  8. Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantation. Am J Transplant. 2011 Jun; 11(6):1236-47.
    View in: PubMed
    Score: 0.029
  9. OKT4A monoclonal antibody immunosuppression of cynomolgus renal allograft recipients. Transplant Proc. 1991 Feb; 23(1 Pt 1):501-3.
    View in: PubMed
    Score: 0.029
  10. Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance. Transplantation. 2010 Dec 27; 90(12):1607-15.
    View in: PubMed
    Score: 0.029
  11. Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery. 1990 Aug; 108(2):406-13; discussion 413-4.
    View in: PubMed
    Score: 0.028
  12. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J Immunol. 1990 Jun 15; 144(12):4604-12.
    View in: PubMed
    Score: 0.027
  13. Fc-receptor for mouse IgG1 (Fc gamma RII) and antibody-mediated cell clearance in patients treated with Leu2a antibody. Transplantation. 1989 Dec; 48(6):1012-7.
    View in: PubMed
    Score: 0.026
  14. A critical analysis of serum and urine interleukin-2 receptor assays in renal allograft recipients. Transplantation. 1989 Nov; 48(5):800-5.
    View in: PubMed
    Score: 0.026
  15. A critical analysis of serum and urine interleukin 2 receptor assays in renal allograft recipients. Transplant Proc. 1989 Feb; 21(1 Pt 2):1863.
    View in: PubMed
    Score: 0.025
  16. Anti-Leu2a (anti-CD8) monoclonal antibody therapy: antibody-mediated cell clearance in vivo requires Fc-FcRII interaction. Transplant Proc. 1989 Feb; 21(1 Pt 1):117-8.
    View in: PubMed
    Score: 0.025
  17. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med. 2008 Jan 24; 358(4):353-61.
    View in: PubMed
    Score: 0.023
  18. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant. 2006 Sep; 6(9):2121-33.
    View in: PubMed
    Score: 0.021
  19. In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients. Transplantation. 1999 Jan 27; 67(2):253-8.
    View in: PubMed
    Score: 0.012
  20. Humanized IgG1 and IgG4 anti-CD4 monoclonal antibodies: effects on lymphocytes in the blood, lymph nodes, and renal allografts in cynomolgus monkeys. Transplantation. 1998 Mar 15; 65(5):632-41.
    View in: PubMed
    Score: 0.012
  21. Functional consequences of anti-ICAM-1 (CD54) in cynomolgus monkeys with renal allografts. Transplant Proc. 1991 Feb; 23(1 Pt 1):279-80.
    View in: PubMed
    Score: 0.007
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.